TRISYNTEC, Inc., a US-based Public Benefit Corporation (PBC), is pleased to announce that the HSBC Life Science and Healthcare Innovation Banking unit has completed its onboarding process.  The investment banking relationship will be with its San Francisco Innovation Banking office.  As an international capital support resource, it will accelerate our MedTech digital health presence in the APAC region, to include the African WHO joint venture initiative, the NMMi diagnostic, an at-home, wearable medical therapeutic device, and the development of our predictive AI epidemiology platform product commercialization's in the US, the EU, and the Middle East.